Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy

V Rinaldi; A Zullo; V De Francesco; Cesare Hassan; S Winn; V Stoppino; D Faleo; Af Attili

Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy

V Rinaldi, A Zullo, V De Francesco, Cesare Hassan, S Winn, V Stoppino, D Faleo, Af Attili

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

It has been suggested that short-term triple therapy comprising a proton pump inhibitor, plus clarithromycin and amoxycillin be used as first choice in treating H. pylori infection, while eradication failure patients should be further treated with a quadruple therapy. Nevertheless, conflicting results have been reported using these treatment regimens in different countries.

Lingua originale	English
pagine (da-a)	163-168
Numero di pagine	6
Rivista	ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume	13
Stato di pubblicazione	Pubblicato - 1999
Pubblicato esternamente	Sì

Keywords

Adolescent
Adult
Aged
Bismuth
Drug Therapy, Combination
Female
Helicobacter Infections
Helicobacter pylori
Histamine H2 Antagonists
Humans
Male
Middle Aged
Proton Pumps
Ranitidine

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{4d5b5b831f3d412f96f143cbe3d72efe,

title = "Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy",

abstract = "It has been suggested that short-term triple therapy comprising a proton pump inhibitor, plus clarithromycin and amoxycillin be used as first choice in treating H. pylori infection, while eradication failure patients should be further treated with a quadruple therapy. Nevertheless, conflicting results have been reported using these treatment regimens in different countries.",

keywords = "Adolescent, Adult, Aged, Bismuth, Drug Therapy, Combination, Female, Helicobacter Infections, Helicobacter pylori, Histamine H2 Antagonists, Humans, Male, Middle Aged, Proton Pumps, Ranitidine, Adolescent, Adult, Aged, Bismuth, Drug Therapy, Combination, Female, Helicobacter Infections, Helicobacter pylori, Histamine H2 Antagonists, Humans, Male, Middle Aged, Proton Pumps, Ranitidine",

author = "V Rinaldi and A Zullo and {De Francesco}, V and Cesare Hassan and S Winn and V Stoppino and D Faleo and Af Attili",

year = "1999",

language = "English",

volume = "13",

pages = "163--168",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "Blackwell Science Limited:PO Box 88, Oxford OX2 0NE United Kingdom:011 44 1865 776868, 011 44 1865 206038, EMAIL: journals.cs@blacksci.co.uk, INTERNET: http://www.blackwell-science.com, Fax: 011 44 1865 721205",

}

TY - JOUR

T1 - Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy

AU - Rinaldi, V

AU - Zullo, A

AU - De Francesco, V

AU - Hassan, Cesare

AU - Winn, S

AU - Stoppino, V

AU - Faleo, D

AU - Attili, Af

PY - 1999

Y1 - 1999

N2 - It has been suggested that short-term triple therapy comprising a proton pump inhibitor, plus clarithromycin and amoxycillin be used as first choice in treating H. pylori infection, while eradication failure patients should be further treated with a quadruple therapy. Nevertheless, conflicting results have been reported using these treatment regimens in different countries.

AB - It has been suggested that short-term triple therapy comprising a proton pump inhibitor, plus clarithromycin and amoxycillin be used as first choice in treating H. pylori infection, while eradication failure patients should be further treated with a quadruple therapy. Nevertheless, conflicting results have been reported using these treatment regimens in different countries.

KW - Adolescent

KW - Adult

KW - Aged

KW - Bismuth

KW - Drug Therapy, Combination

KW - Female

KW - Helicobacter Infections

KW - Helicobacter pylori

KW - Histamine H2 Antagonists

KW - Humans

KW - Male

KW - Middle Aged

KW - Proton Pumps

KW - Ranitidine

KW - Adolescent

KW - Adult

KW - Aged

KW - Bismuth

KW - Drug Therapy, Combination

KW - Female

KW - Helicobacter Infections

KW - Helicobacter pylori

KW - Histamine H2 Antagonists

KW - Humans

KW - Male

KW - Middle Aged

KW - Proton Pumps

KW - Ranitidine

UR - http://hdl.handle.net/10807/34622

M3 - Article

SN - 0269-2813

VL - 13

SP - 163

EP - 168

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

ER -

Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy

Abstract

Keywords

Altri file e collegamenti

Fingerprint

Cita questo